. 2020 Apr;147(2):309-315.

doi: 10.1007/s11060-020-03424-9. Epub 2020 Feb 13.

A genome-wide association study on medulloblastoma

Anna M Dahlin¹, Carl Wibom¹, Ulrika Andersson¹, Jonas Bybjerg-Grauholm², Isabelle Deltour^{3

4}, David M Hougaard², Michael E Scheurer⁵, Ching C Lau⁵, Roberta McKean-Cowdin⁶, Rebekah J Kennedy⁷, Long T Hung⁸, Janis Yee⁸, Ashley S Margol⁸, Jessica Barrington-Trimis⁶, W James Gauderman⁶, Maria Feychting⁹, Joachim Schüz³, Martin Röösli^{10

11}, Kristina Kjaerheim¹²; Cefalo Study Group; Danuta Januszkiewicz-Lewandowska^{13

14}, Marta Fichna¹⁵, Jerzy Nowak¹³, Susan Searles Nielsen^{16

17}, Shahab Asgharzadeh^{8

18}, Lisa Mirabello¹⁹, Ulf Hjalmars¹, Beatrice Melin²⁰

Collaborators, Affiliations

Collaborators

Cefalo Study Group:
Michaela Prochazka, Maral Adel Fahmideh, Birgitta Lannering, Lisbeth S Schmidt, Christoffer Johansen, Astrid Sehested, Claudia Kuehni, Michael Grotzer, Tore Tynes, Tone Eggen, Lars Klæboe

Affiliations

¹ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
² Danish Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
³ Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.
⁴ Unit of Statistics, Bioinformatics and Registry, Danish Cancer Society Research Center, Copenhagen, Denmark.
⁵ Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁶ Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁷ Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
⁸ Department of Pediatrics, Section of Hematology-Oncology, Children's Hospital Los Angeles and The Saban Research Institute, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
⁹ Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
¹¹ University of Basel, Basel, Switzerland.
¹² The Cancer Registry of Norway, Oslo, Norway.
¹³ Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
¹⁴ Department of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
¹⁵ Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
¹⁶ Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁷ Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA.
¹⁸ Department of Pathology, Saban Research Institute at Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
²⁰ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. beatrice.melin@umu.se.

PMID: 32056145
PMCID: PMC7136185
DOI: 10.1007/s11060-020-03424-9

A genome-wide association study on medulloblastoma

Anna M Dahlin et al. J Neurooncol. 2020 Apr.

. 2020 Apr;147(2):309-315.

doi: 10.1007/s11060-020-03424-9. Epub 2020 Feb 13.

Authors

Collaborators

Cefalo Study Group:
Michaela Prochazka, Maral Adel Fahmideh, Birgitta Lannering, Lisbeth S Schmidt, Christoffer Johansen, Astrid Sehested, Claudia Kuehni, Michael Grotzer, Tore Tynes, Tone Eggen, Lars Klæboe

Affiliations

¹ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
² Danish Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
³ Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France.
⁴ Unit of Statistics, Bioinformatics and Registry, Danish Cancer Society Research Center, Copenhagen, Denmark.
⁵ Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁶ Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁷ Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
⁸ Department of Pediatrics, Section of Hematology-Oncology, Children's Hospital Los Angeles and The Saban Research Institute, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
⁹ Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
¹¹ University of Basel, Basel, Switzerland.
¹² The Cancer Registry of Norway, Oslo, Norway.
¹³ Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
¹⁴ Department of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland.
¹⁵ Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
¹⁶ Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁷ Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA.
¹⁸ Department of Pathology, Saban Research Institute at Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
¹⁹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
²⁰ Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. beatrice.melin@umu.se.

PMID: 32056145
PMCID: PMC7136185
DOI: 10.1007/s11060-020-03424-9

Abstract

Introduction: Medulloblastoma is a malignant embryonal tumor of the cerebellum that occurs predominantly in children. To find germline genetic variants associated with medulloblastoma risk, we conducted a genome-wide association study (GWAS) including 244 medulloblastoma cases and 247 control subjects from Sweden and Denmark.

Methods: Genotyping was performed using Illumina BeadChips, and untyped variants were imputed using IMPUTE2.

Results: Fifty-nine variants in 11 loci were associated with increased medulloblastoma risk (p < 1 × 10^-5), but none were statistically significant after adjusting for multiple testing (p < 5 × 10^-8). Thirteen of these variants were genotyped, whereas 46 were imputed. Genotyped variants were further investigated in a validation study comprising 249 medulloblastoma cases and 629 control subjects. In the validation study, rs78021424 (18p11.23, PTPRM) was associated with medulloblastoma risk with OR in the same direction as in the discovery cohort (OR_T = 1.59, p_validation = 0.02). We also selected seven medulloblastoma predisposition genes for investigation using a candidate gene approach: APC, BRCA2, PALB2, PTCH1, SUFU, TP53, and GPR161. The strongest evidence for association was found for rs201458864 (PALB2, OR_T = 3.76, p = 3.2 × 10^-4) and rs79036813 (PTCH1, OR_A = 0.42, p = 2.6 × 10^-3).

Conclusion: The results of this study, including a novel potential medulloblastoma risk loci at 18p11.23, are suggestive but need further validation in independent cohorts.

Keywords: Adolescents and young adults (AYA); CNS cancers; Epidemiology; Genetics of risk, outcome, and prevention; Pediatric cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

**Fig. 1**
Manhattan plot. P-values for the association between 9,204,561 genetic variants and medulloblastoma risk. Both genotyped and imputed SNPs are included. Solid line indicates genome-wide statistical significance (p = 5 × 10^–8). Dashed line indicates p = 1 × 10^–5

See this image and copyright information in PMC

References

1. Hottinger AF, Khakoo Y. Neurooncology of familial cancer syndromes. J Child Neurol. 2009;24:1526–1535. doi: 10.1177/0883073809337539. - DOI - PubMed
1. Smith MJ, Beetz C, Williams SG, et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J Clin Oncol. 2014;32:4155–4161. doi: 10.1200/JCO.2014.58.2569. - DOI - PubMed
1. Waszak SM, Northcott PA, Buchhalter I, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018;19:785–798. doi: 10.1016/S1470-2045(18)30242-0. - DOI - PMC - PubMed
1. Begemann M, Waszak SM, Robinson GW, et al. Germline GPR161 mutations predispose to pediatric medulloblastoma. J Clin Oncol. 2020;38:43–50. doi: 10.1200/JCO.19.00577. - DOI - PMC - PubMed
1. Northcott PA, Korshunov A, Pfister SM, Taylor MD. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol. 2012;8:340–351. doi: 10.1038/nrneurol.2012.78. - DOI - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A genome-wide association study on medulloblastoma

Collaborators

Affiliations

A genome-wide association study on medulloblastoma

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

Figures

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous